Skip to content

Synergus RWE is now part of athagoras Medtech. For current services and contact, visit medtech.athagoras.com

Go to athagoras Medtech
Synergus RWE
← Archived pages

2 abstracts presented from Diabetes RWE research

Synergus RWE has contributed to this important study to demonstrate the value of FreeStyle Libre, utilising the rich data from Swedish diabetes registry linked with several other data-sources. These two abstracts are a result from this:

Nathanson D, Eeg-Olofsson K, Spelman T, et al. Intermittently-scanned CGM is associated with lower HbA1c and reduced hospital admissions for adults with T2DM on insulin therapy in Sweden: a retrospective controlled study. Presented at EASD, 2 - 6 October 2023, Hamburg, Germany.

Nathanson D, Eeg-Olofsson K, Spelman T, et al. Retrospective controlled study shows intermittently-scanned CGM is associated with lower HbA1c and reduced hospitalisation for diabetes events in adults with T1DM in Sweden. Presented at EASD, 2 - 6 October 2023, Hamburg, Germany.

In this blog, you can learn more about the different data sources that can be linked to Diabetes Research.